MARI FINLEY: Open Payments
NPI 1942575329 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 19 payments from 11 companies in 2025. Trend: 2023 $20 · 2024 $107 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Lilly USA, LLC | 3 | $53 |
| Medtronic, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Astellas Pharma US Inc | 2 | $34 |
| Exact Sciences Corporation | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
Products named: AIRSUPRA, MOUNJARO, INCEPTIV, Veozah, INSPIRE, Rybelsus, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
